Cargando…

A risk prediction model for heart failure hospitalization in type 2 diabetes mellitus

BACKGROUND: Antidiabetic therapies have shown disparate effects on hospitalization for heart failure (HHF) in clinical trials. This study developed a prediction model for HHF in type 2 diabetes mellitus (T2DM) using real world data to identify patients at high risk for HHF. HYPOTHESIS: Type 2 diabet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Brent A., Geba, Daniela, Cordova, Jeanine M., Shetty, Sharash S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2019
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068070/ https://www.ncbi.nlm.nih.gov/pubmed/31837035 http://dx.doi.org/10.1002/clc.23298

Ejemplares similares

Depressive symptoms in asymptomatic stage B heart failure with Type II diabetic mellitus
por: Mills, Paul J., et al.
Publicado: (2019)

Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 Diabetes Mellitus
por: Yang, Xilin, et al.
Publicado: (2008)

Heart failure documentation in outpatients with diabetes and volume overload: an observational cohort study from the Diabetes Collaborative Registry
por: Arnold, Suzanne V., et al.
Publicado: (2020)

Association of depression with evolution of heart failure in patients with type 2 diabetes mellitus
por: Wang, Ying, et al.
Publicado: (2018)

Peroxiredoxin isoforms are associated with cardiovascular risk factors in type 2 diabetes mellitus
por: El Eter, E., et al.
Publicado: (2015)

Clinical outcomes by serum potassium levels for patients hospitalized for heart failure: Secondary analysis of data from the China National Heart Failure Registry
por: Zhou, Jingmin, et al.
Publicado: (2023)

Are there differences in acute phase inflammation markers regarding the type of heart failure?
por: Sánchez-Lázaro, Ignacio J., et al.
Publicado: (2011)

Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure
por: Soga, Fumitaka, et al.
Publicado: (2018)

Vaccine‐preventable disease hospitalized patients with heart failure with reduced ejection fraction
por: Del Cid Fratti, Juan, et al.
Publicado: (2022)

The predictive value of weight gain and waist circumference for gestational diabetes mellitus
por: Takmaz, Taha, et al.
Publicado: (2019)

Impact of insulin therapy on the mortality of acute heart failure patients with diabetes mellitus
por: Jang, Se Yong, et al.
Publicado: (2021)

Practical cardiovascular risk calculator for asymptomatic patients with type 2 diabetes mellitus: PRECISE‐DM risk score
por: Choi, Young, et al.
Publicado: (2020)

Hypoglycemia Incidence Rates and Associated Health Care Costs in Patients with Type 2 Diabetes Mellitus Treated with Second-Line Linagliptin or Sulfonylurea After Metformin Monotherapy
por: Raju, Aditya, et al.
Publicado: (2016)

Soluble ST2 in the prediction of heart failure and death in patients with atrial fibrillation
por: Krittayaphong, Rungroj, et al.
Publicado: (2022)

Prevalence, clinical characteristics, and predictors of sleep disordered breathing in hospitalized heart failure patients
por: Huang, Boping, et al.
Publicado: (2022)

Prognostic role and relationship of thyroid dysfunction and lipid profile in hospitalized heart failure patients
por: Zhou, Ping, et al.
Publicado: (2023)

Riboflavin alleviates cardiac failure in Type I diabetic cardiomyopathy
por: Wang, Guoguang, et al.
Publicado: (2011)

Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control
por: Wai, Bryan, et al.
Publicado: (2012)

Positive effect of dapagliflozin on left ventricular longitudinal function for type 2 diabetic mellitus patients with chronic heart failure
por: Tanaka, Hidekazu, et al.
Publicado: (2020)

Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure
por: Kobayashi, Masatake, et al.
Publicado: (2021)

QT and Tpeak‐Tend interval variability: Predictive electrical markers of hospital stay length and mortality in acute decompensated heart failure. Preliminary data
por: Piccirillo, Gianfranco, et al.
Publicado: (2022)

Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2017)

Diabetes mellitus and congestive heart failure: the prevalence of congestive heart failure in patients with and without diabetes in Poland
por: Wierzba, Waldemar, et al.
Publicado: (2018)

Genetic analysis of the ELOVL6 gene polymorphism associated with type 2 diabetes mellitus
por: Liu, Y., et al.
Publicado: (2013)

Impact of diabetes on the predictive value of heart failure biomarkers
por: Alonso, Nuria, et al.
Publicado: (2016)

Ejection fraction, B‐type natriuretic peptide and risk of stroke and acute myocardial infarction among patients with heart failure
por: Greenberg, Barry, et al.
Publicado: (2019)

The risk of hospitalization and modality failure with home dialysis
por: Suri, Rita S, et al.
Publicado: (2015)

First symptoms and health care pathways in hospitalized patients with acute heart failure: ICPS2 survey. A report from the Heart Failure Working Group (GICC) of the French Society of Cardiology
por: Beauvais, Florence, et al.
Publicado: (2021)

Initiating ivabradine during hospitalization in patients with acute heart failure: A real‐world experience in China
por: Liu, Ying‐Xian, et al.
Publicado: (2022)

Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus
por: Atamer, Y., et al.
Publicado: (2013)

Tailored risk assessment of 90‐day acute heart failure readmission or all‐cause death to heart failure with preserved versus reduced ejection fraction
por: Park, Jaeyoung, et al.
Publicado: (2022)

Prospective evaluation of the multisensor HeartLogic algorithm for heart failure monitoring
por: Santini, Luca, et al.
Publicado: (2020)

Impact of diabetes mellitus on mortality in patients with acute heart failure: a prospective cohort study
por: Kong, Min Gyu, et al.
Publicado: (2020)

Mode of death in elderly and super‐elderly patients with acute heart failure: Insights from Japanese heart failure registry
por: Takabayashi, Kensuke, et al.
Publicado: (2021)

Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus
por: Gu, Jun, et al.
Publicado: (2018)

The predictive value of changes in left atrial volume index for rehospitalization in heart failure with preserved ejection fraction
por: Hao, Zhujing, et al.
Publicado: (2022)

Patients' Self-Assessed Functional Status in Heart Failure by New York Heart Association Class: A Prognostic Predictor of Hospitalizations, Quality of Life and Death
por: Holland, Richard, et al.
Publicado: (2010)

Role of microRNAs in the treatment of type 2 diabetes mellitus with Roux-en-Y gastric bypass
por: Zhu, Z., et al.
Publicado: (2017)

Patients hospitalized with acute heart failure, worsening renal function, and persistent congestion are at high risk for adverse outcomes despite current medical therapy
por: Cooper, Lauren, et al.
Publicado: (2023)

Healthcare Costs and Resource Utilization Associated with the Use of Empagliflozin Versus Other Antihyperglycemic Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Real-World Retrospective Cohort Analysis
por: Raju, Aditya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u0idf8ravp11tlio38agk0at7k